Floatz logo

Cilostazol

Ischemic Stroke

Stanford UniversityUNKNOWNPhase 4 / ApprovedActive
BBB
74/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
80/ 100
Competitive Position
65/ 100

Competitive context

197 Active assets in the Ischemic Stroke cohort.

Asset / SponsorPhaseRating
Ticagrelor
Sichuan Provincial People's Hospital
Phase 4BBB
Compound Edaravone
Nanfang Hospital, Southern Medical University
Phase 4BBB
Tenecteplase
Hackensack Meridian Health
Phase 4BBB
Argatroban
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 4BBB
3-N-BUTYLPHTHALIDE
Nanfang Hospital, Southern Medical University
Phase 4BBB

View all 50 →

Same molecule, other indications

Cilostazol is also rated in:

cerebral infarctionActive
BBB
Indicative · Phase 4
79 / 100
View asset →
transient ischemic attackActive
BBB
Indicative · Phase 4
75 / 100
View asset →
stroke disorderActive
BB
Indicative · Phase 4
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →